* Nutex Health Inc NUTX.OQ reported quarterly breakeven
results per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -2 cents. The lone analyst forecast for the quarter was
for breakeven results per share.
* Revenue rose 29.7% to $69.67 million from a year ago;
analysts
expected $71.40 million.
* Nutex Health Inc's reported EPS for the quarter was a loss
of 5
cents.
* The company reported a quarterly loss of $31.62 million.
* Nutex Health Inc shares had fallen by 43.3% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 100%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Nutex Health Inc
is $1.00
This summary was machine generated from LSEG data March 29 at
01:15 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.00 0.00 Met
Sep. 30 2023 0.00 -0.01 Missed
Jun. 30 2023 0.00 -0.01 Missed
Mar. 31 2023 -0.01 -0.01 Met